Studies: Celebrex doubles risk of serious heart problems

08/30/2006 | USA Today

Two studies suggest Celebrex, a pain reliever believed to help prevent colorectal polyps, poses such a danger to the heart that patients were warned not to take it to prevent colorectal disease. The Pfizer-made drug was shown to dramatically reduce the risk of recurrent polyps that can lead to cancer, but researchers found it doubled the risk of serious heart problems at the same time.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC